Therefore, the continuous inactive stage of the Allograft Rejection pathways, PI3K/Akt pathway and MAPK pathway may be possible by quitting smoking at an early period or taking drugs to alter the current active status of the pathways in T2D patients. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.